Technology

A new classification system helps patients reach informed decisions.

Six topics were assessed in the report, including global data on myopia prevalence, technology, environmental and genetic contributions to myopia onset and progression, and mechanistic causes of myopia pathogenesis, among others.

Navigation and orientation technologies offer practical solution for people with vision loss.

As much as 96% of customers and 60% of patients can get their results in less than a minute with Retinalyze, according to the company.

MeiboMetrics is scheduled to be available on several platforms starting in 2025.

NextGen Healthcare's NextGen Ambient Assist is able to recognize medical acronyms and provides automation for both uploading information into the EHR and deleting audio and transcripts to ensure patient privacy is protected.

The Finnish company's new device sports a universal adapter and rebound tonometry technology.

Young will be aiding in expanding real-world evidence programs to promotion the adoption of Brightstar’s BrightMEM corneal allograft for the treatment of limbal stem cell deficiency and persistent epithelial defects.

Researchers at the Medical College of Georgia at Augusta University are teaming up with Polaris Dawn to investigate how eye changes astronauts may experience during spaceflight could lead to multiple symptoms once back on Earth.

Injectsense's future plans for the sensor are to fine-tune its delivery tool and incorporate a microbattery into the sensor.

The device features cross-polarized light technology, allowing for image clarity without the need for pupil dilation.

Understanding the latest innovative technologies.

As many as 14 risk factors have now been found for dementia.

Utilizing artificial intelligence may provide feasibility assessments, data-driven protocol design, and cost reduction opportunities.

Ambient listening and transcription provide promising impact on the patient care experience.

Belkin Vision is the developer of Vision Eagle direct selective laser trabeculoplasty technology.

Aiming to address long-standing challenges without sacrificing accuracy.

Technological advancements may improve treatment options.

MyopiaX is a non-invasive, light-based treatment that uses a virtual reality headset to deliver treatment while patients engage with digital content.

North Bay Eye Associates transitions from traditional bowl perimeter to portable vision diagnostic and patient engagement system.

The Tono-Vera Tonometer allows for automated IOP measurements and eliminates the need for a topical anesthetic.

Providing prevention strategies can keep patients comfortable during allergy season.

The SCANLY Home OCT device allows physicians to monitor patients’ wet age-related macular degeneration in between visits through a health cloud portal.

The microemulsion drug ocular penetration system platform technology was found to effectively formulate and deliver lipophilic molecules via topical eye drops.

Preventive options should be as important as treating symptoms

The diagnostic aid platform, C.DIAG, utilizes artificial intelligence to assist with the diagnosis and treatment of dry eye disease.

The AI-powered eye diagnostic innovator and medical devices and software solutions company have announced a collaboration to promote an AI diagnostic tool that assesses risk to brain health via retinal imaging.

Joseph Izatt, PhD, was known for his excellence in mentorship and his work as a researcher that helped develop and advance optical coherence tomography technology, according to a news release.

UC Berkeley’s Herbert Wertheim School of Optometry and Vision Science integrated the new laser in the beginning of March in its dry eye clinic for treatment of meibomian gland dysfunction.

The AI-powered model works to detect early signs of glaucoma and makes iHealthScreen the first company to receive 2 US patents for AMD and glaucoma screening devices.